PubRank

D R Vlock

Author PubWeight™ 11.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A 1992 1.58
2 High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma. J Natl Cancer Inst 1990 1.51
3 Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393. J Clin Oncol 2001 0.94
4 Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma. J Immunother Emphasis Tumor Immunol 1993 0.93
5 Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum. Cancer Res 1984 0.86
6 Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma. Cancer 2000 0.85
7 Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes. J Clin Invest 1985 0.80
8 Prognostic role of antibody reactivity to melanoma. J Clin Invest 1986 0.78
9 Tomographic gallium-67 citrate scanning: useful new surveillance for metastatic melanoma. Ann Intern Med 1982 0.77
10 Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice. Cancer Chemother Pharmacol 1993 0.77
11 Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model. Cancer Res 1994 0.77
12 Tomographic gallium-67 citrate scanning. Useful new surveillance for metastatic melanoma. Ann Surg 1983 0.75
13 High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy. Cancer 1982 0.75
14 Cross-reactivity between murine melanoma antigen B700 and a human melanoma-associated antigen (M-66) recognized by autologous antibody: evidence suggesting shared epitopes. Biochim Biophys Acta 1993 0.75
15 Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients. J Immunother 1997 0.75